| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |